Dexamethasone intravitreal implant

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Macular edema, central retinal vein occlusion

Manufacturer:

Allergan

Call for patient/clinician input open:

August 19, 2011

Brand Name:

Ozurdex

Project Line:

Reimbursement Review

Project Number:

SR0247-000

Call for patient/clinician input closed:

September 23, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Macular edema following central retinal vein occlusion

Recommendation Type:

Do not list

Final Recommendation:

April 25, 2012

Last Updated : September 1, 2011